Bellicum Pharmaceuticals, Inc. (BLCM): Price and Financial Metrics

Bellicum Pharmaceuticals, Inc. (BLCM): $0.48

0.11 (+29.02%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add BLCM to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#364 of 502

in industry

BLCM Price/Volume Stats

Current price $0.48 52-week high $1.50
Prev. close $0.37 52-week low $0.15
Day low $0.32 Volume 5,435
Day high $0.48 Avg. volume 1,068,907
50-day MA $0.41 Dividend yield N/A
200-day MA $0.63 Market Cap 4.56M

BLCM Stock Price Chart Interactive Chart >


Bellicum Pharmaceuticals, Inc. (BLCM) Company Bio


Bellicum Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including hematological cancers and solid tumors, as well as orphan inherited blood disorders. The company was founded in 2004 and is based in Houston, Texas.


BLCM Latest News Stream


Event/Time News Detail
Loading, please wait...

BLCM Latest Social Stream


Loading social stream, please wait...

View Full BLCM Social Stream

Latest BLCM News From Around the Web

Below are the latest news stories about BELLICUM PHARMACEUTICALS INC that investors may wish to consider to help them evaluate BLCM as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off the day with the biggest pre-market stock movers traders will want to keep in mind while trading on Tuesday!

William White on InvestorPlace | May 9, 2023

Why Is Immuron (IMRN) Stock Up 67% Today?

Immuron (IMRN) stock is gaining on Monday thanks to an update from the Food and Drug Administration (FDA) on a clinical hold.

William White on InvestorPlace | May 8, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Pre-market stock movers are a hot topic on Monday as we dive into the biggest winners and losers traders need to know about this morning!

William White on InvestorPlace | May 8, 2023

Why Is Aptorum (APM) Stock Down 16% Today?

Aptorum (APM) stock is falling on Monday after the biopharmaceutical company received a delisting notice from the Nasdaq.

William White on InvestorPlace | May 8, 2023

Why Is Bellicum Pharmaceuticals (BLCM) Stock Up 75% Today?

Bellicum Pharmaceuticals (BLCM) stock is rising higher on Monday morning following news of an investment in the company.

William White on InvestorPlace | May 8, 2023

Read More 'BLCM' Stories Here

BLCM Price Returns

1-mo -4.00%
3-mo 37.14%
6-mo 68.90%
1-year -60.33%
3-year -93.38%
5-year -99.22%
YTD -33.33%
2022 -51.68%
2021 -57.79%
2020 -72.64%
2019 -55.82%
2018 -65.28%

Continue Researching BLCM

Want to see what other sources are saying about Bellicum Pharmaceuticals Inc's financials and stock price? Try the links below:

Bellicum Pharmaceuticals Inc (BLCM) Stock Price | Nasdaq
Bellicum Pharmaceuticals Inc (BLCM) Stock Quote, History and News - Yahoo Finance
Bellicum Pharmaceuticals Inc (BLCM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!